WASHINGTON, May 23 -- U.S. Customs and Border Protection has issued a notice called: Notice of Issuance of Final Determination Concerning Biomedix Selec-3 Multiple Drop Intravenous Product.

The notice was published in the Federal Register on May 23 by Alice A. Kipel, Executive Director, Regulations and Rulings, Office of Trade.

Summary: This document provides notice that U.S. Customs and Border Protection (CBP) has issued a final determination concerning the country of origin of the Biomedix Selec-3 Multiple Drop Intravenous Product. Based upon the facts presented, CBP has concluded that the subject IV products, under two of five scenarios, would be the product of a foreign country or instrumentality designated pursuant to title III of th...